Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi<sup>8</sup>,Met(O<sub>2</sub>)<sup>11</sup>]-Substance P

Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi<sup>8</sup>,Met(O<sub>2</sub>)<sup>11</sup>]-Substance P

Radiopharmaceutical development hinges on the affinity and selectivity of the biological component for the intended target. An analogue of the neuropeptide Substance P (SP), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi<sup>8</sup>,Met(O<sub>2</sub>)<sup>...

Full description

Bibliographic Details
Main Authors: Janine Suthiram, Ané Pieters, Zulfiah Mohamed Moosa, Jan Rijn Zeevaart, Mike M. Sathekge, Thomas Ebenhan, Ross C. Anderson, Claire L. Newton
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
neurokinin-1 receptor
neurokinin-2 receptor
neurokinin-3 receptor
mas-related G protein-coupled receptor subtype 2
receptor selectivity
DOTA-[Thi<sup>8</sup>,Met(O<sub>2</sub>)<sup>11</sup>]SP
Online Access:https://www.mdpi.com/1422-0067/24/3/2134

Internet

https://www.mdpi.com/1422-0067/24/3/2134

Similar Items